利用新型多亲本小鼠模型揭示X连锁Alport综合征的修饰基因
研究利用多样性远交小鼠资源构建遗传多样性X连锁Alport综合征雄性和雌性小鼠队列,测量白蛋白尿、GFR和基因表达,通过数量性状位点方法定位修饰基因。遗传分析发现与白蛋白尿和GFR变异相关的多个位点,包括X染色体上与X失活相关的位点及2号染色体含Fmn1的位点;在Col4a5敲除小鼠中遗传性降低Fmn1表达后,白蛋白尿、足细胞足突消失和基底膜足细胞突起均减少,支持Fmn1作为Alport综合征修饰基因的候选。
要点
- 多样性远交小鼠可模拟Alport综合征患者肾脏表型严重程度的变异性。
- 定位到与白蛋白尿和GFR变异相关的多个位点,包括X染色体和2号染色体Fmn1区域。
- 降低Fmn1表达可减轻Col4a5敲除小鼠的白蛋白尿和足细胞损伤。
核心结论
- 通过白蛋白尿和GFR测量,该新型方法可模拟Alport综合征患者肾脏表型严重程度的变异性,并识别可用作新治疗靶点的肾脏疾病修饰基因。
研究设计与样本
- 研究利用多样性远交小鼠资源构建遗传多样性X连锁Alport综合征雄性和雌性小鼠队列,测量白蛋白尿、GFR和基因表达。
- 采用数量性状位点方法定位最能解释多样群体中所测表型变异的修饰基因。
主要发现
- 遗传分析识别出多个与白蛋白尿和GFR变异相关的位点,包括X染色体上与X失活相关的位点及2号染色体含Fmn1的位点。
- 在Col4a5敲除小鼠中遗传性降低Fmn1表达后,白蛋白尿、足细胞足突消失和肾小球基底膜足细胞突起均减少。
临床怎么用
- 该研究提示修饰基因可作为Alport综合征潜在治疗靶点,但尚未提供临床可直接应用的阈值或干预方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Mutations in COL4A5 are responsible for 80% of cases of X-linked Alport Syndrome (XLAS). Although genes that cause AS are well characterized, people with AS who have similar genetic mutations present with a wide variation in the extent of kidney impairment and age of onset, suggesting the activities of modifier genes. METHODS: We created a cohort of genetically diverse XLAS male and female mice using the Diversity Outbred mouse resource and measured albuminuria, GFR, and gene expression. Using a quantitative trait locus approach, we mapped modifier genes that can best explain the underlying phenotypic variation measured in our diverse population. RESULTS: Genetic analysis identified several loci associated with the variation in albuminuria and GFR, including a locus on the X chromosome associated with X inactivation and a locus on chromosome 2 containing Fmn1. Subsequent analysis of genetically reduced Fmn1 expression in Col4a5 knockout mice showed a decrease in albuminuria, podocyte effacement, and podocyte protrusions in the glomerular basement membrane, which support the candidacy of Fmn1 as a modifier gene for AS. CONCLUSION: With this novel approach, we emulated the variability in the severity of kidney phenotypes found in human patients with Alport Syndrome through albuminuria and GFR measurements. This approach can identify modifier genes in kidney disease that can be used as novel therapeutic targets.
引用
- Takemon Y, Wright V, Davenport B, et al. Uncovering Modifier Genes of X-Linked Alport Syndrome Using a Novel Multiparent Mouse Model. J Am Soc Nephrol. 2021. PMID: 34045313. doi:10.1681/ASN.2020060777
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。